Chhattisgarh records first Covid death of the year
Chhattisgarh has reported its first Covid death this year. An 86-year-old patient, who had multiple comorbidities and was on regular dialysis, died at a private hospital in Raipur on June 14, officials said on Monday. It's the first fatality in the state linked to the JN1 variant, said officials. Chhattisgarh has recorded 118 Covid-19 infections this year. There are 51 active cases in the state.
Raipur: Chhattisgarh has reported its first Covid death this year. An 86-year-old patient, who had multiple comorbidities and was on regular dialysis, died at a private hospital in Raipur on June 14, officials said on Monday.
It's the first fatality in the state linked to the JN1 variant, said officials.
Chhattisgarh has recorded 118 Covid-19 infections this year. There are 51 active cases, of whom 41 are in home isolation, nine are on oxygen support, and one patient is in ICU.
According to health officials, the 86-year-old, a native of Rajnandgaon, had multiple comorbidities, including chronic renal failure, hypertension, and interstitial lung disease. His condition worsened, and he tested positive for Covid during routine screening. He died on the same day due to complications related to his health issues, said officials.
On Monday, the state reported 10 new cases, including three each from Raipur and Bilaspur, two from Durg and 1 each from Mahasamund and Surguja.
The daily growth rate of Covid-19 stands at 23.1%, while the recovery rate is twice that at 56.4%. Health experts predict that the state could see around 50 more cases in the next 10 days, but three patients on average are recovering each day.
Health authorities said that they are on alert after the Covid death.
The govt has begun training technical and non-technical healthcare staff in district hospitals and health centres in sample collection and patient treatment. Covid cases have been recorded in nine districts - including Raipur, Durg, Bilaspur, Bastar, Surguja, Mahasamund and Bemetara. Health department has urged people with cold and flu symptoms to get tested for Covid.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
3 hours ago
- News18
New Covid Variant ‘Nimbus' Spreads In US, Causes Painful ‘Razor Blade Throat'. What Is It?
Last Updated: Known scientifically as NB.1.8.1, the variant is currently being monitored by the World Health Organization (WHO) and was first detected in China earlier this year. A newly emerging Covid-19 subvariant 'Nimbus' is gaining ground in the United States, causing a distinctive and extremely painful sore throat, commonly described by patients as 'razor blade throat." Known scientifically as NB.1.8.1, the variant is currently being monitored by the World Health Organization (WHO) and was first detected in China earlier this year. According to data from the Centers for Disease Control and Prevention (CDC), Nimbus accounted for approximately 37% of US cases in the two-week period ending June 7. The variant could soon represent up to one-third of global Covid cases, health officials have warned. Nicknamed 'razor throat," the symptom of the Nimbus variant is an intensely painful sore throat, with some patients likening it to 'swallowing shards of glass." This symptom is notably more severe and more common than in previous variants as Dr. Marc Siegel, Fox News' senior medical analyst, said, 'Many of the Covid subvariants have characteristic features. Nimbus is being associated with an unusually sharp sore throat." Other symptoms reported include: nasal congestion or runny nose, fatigue, mild cough, fever, muscle or body aches and nausea or diarrhea. Despite the striking throat pain, Dr. Marc Siegel said that Nimbus does not appear more virulent than earlier strains. Dr. Kenneth Perry, an emergency room physician in South Carolina, noted that the predominant symptoms of Covid continue to shift with each new variant, saying, 'With the new variant, it appears that the sore throat is yet again a prominent symptom. The pain is caused by direct infection and inflammation of the throat's cells." What US Health Agency Has Said On Nimbus? Though the variant is clearly spreading, the CDC noted that NB.1.8.1 is still emerging in terms of genetic sequencing data. A CDC spokesperson told Newsweek that fewer than 20 confirmed genetic sequences of the variant had been documented in US baseline surveillance so far while public health officials remain alert to its rise, particularly in high-population states like California and New York. Dr. Tyler B. Evans, infectious disease expert and CEO of the Wellness and Equity Alliance, said that while Nimbus may not drastically differ from other recent strains, it should still be taken seriously. 'We're still seeing the familiar signs—sore throat, nasal congestion, fatigue, cough," he told Newsweek, adding, 'But in some people, especially the unvaccinated, this can escalate into more severe respiratory symptoms." First Published: June 18, 2025, 18:07 IST
Time of India
5 hours ago
- Time of India
XFG dominant strain, multiple Omicron subvariants spreading in Maharashtra, reveals genome study
Pune: Multiple emerging Covid-19 strains — all Omicron subvariants — were spreading across the state, Maharashtra's genome sequencing surveillance revealed. The latest sequencing data from 184 samples across 10 districts showed XFG as the currently dominant variant with 84 cases. It was followed by 38 unassigned variants, 34 LF.7.9 cases, 27 JN.1 cases and one NB.1.8.1 case detected in Pune. Nine samples from Mumbai were detected with the XFG subvariant, while three others with LF. 7.9. The NB.1.8.1, identified in a 29-year-old woman from Pune, showed high ACE2 affinity and immune evasion, hinting at the variant's potential to dominate future surges as per recent studies. ACE2 acts as a receptor for the spike protein of coronaviruses, allowing the virus to enter host cells. XFG, dominating in Maharashtra, and LF.7.9 are noted for their strong immune escape because of specific mutations, though their lower receptor-binding efficiency may require further adaptations. Dr Rajesh Karyakarte, Maharashtra's genome sequencing coordinator, BJ Medical College, told TOI, "After NB.1.8.1 was identified in Hong Kong as causing a surge in Covid cases, we at BJGMC, Pune, and NIV, Pune, parallelly started sequencing RT-PCR positive Covid-19 samples for the presence of this SARS-CoV-2 variant. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Esse novo alarme com câmera é quase gratuito em Eugenópolis (consulte o preço) Alarmes Undo CSIR-NCL, Pune's study also showed a spike in SARS-CoV-2 signals. Our findings after whole genome sequencing (WGS) revealed XFG to be the most dominant variant in the state, which wasn't a dominant global variant at that time around the world. We also identified LF.7.9 as another major variant in tested samples." Dr Karyakarte said, "The numbers confirm that XFG drove the current surge and not NB.1.8.1 (labelled Variant Under Monitoring [VUM] by WHO). After studying the sequences uploaded on WHO recommended GISAID database, it is clear that NB.1.8.1 is more common in Southeast Asia, while XFG prevails in India, Pakistan and Bangladesh — possibly because of immunity factors. Recently, XFG has also been rising in the US." Dr Ameet Dravid, infectious disease expert, Noble Hospital, said, "XFG is merely an Omicron sub-variant, similar to those in circulation during the third wave in 2022. Thanks to immunity built from previous infections, we're seeing very few severe cases this time. XFG is highly transmissible because of mutations that allow it to spread easily from person to person, leading to many upper respiratory tract infections. Its capacity to damage lungs or cause complications is minimal. So, patients with these symptoms are recovering well with outpatient treatment." Dr Dravid said, "Only a tiny fraction requires admission for pneumonia or ARDS (Acute Respiratory Distress Syndrome), the complications we saw in the first three waves. The damage has been limited despite low vaccination rates and waning vaccine-induced immunity over the last three years. We're relieved there hasn't been a significant surge in Covid admissions. While cases are increasing, most are mild, and improving with symptomatic care like nasal decongestants, cough suppressants and paracetamol for fever or body aches. " Hospitals in the city reported a noticeable uptick in Covid cases this week compared to previous weeks. Daily or alternate-day deaths, mostly among those with pre-existing conditions, have been recorded. The state health data indicated 31 fatalities since January this year — as many as 30 linked to comorbidities and one to another illness. Infectious disease specialists said this trend mirrored past surges. Individuals with underlying health issues remain vulnerable as infections rise. Dr Piyush Chaudhary, infectious disease specialist, Jehangir Hospital, said, "This variant (XFG) appears mild, but even mild strains can lead to some mortality, especially if the number of cases is high. The elderly or those with comorbidities may experience severe outcomes. We also haven't seen worsening severity — patients in ICU were there because of other medical conditions, not Covid itself. We must determine if Covid contributed to deaths or if underlying comorbidities were the primary cause. Currently, it seems, comorbidities, not Covid, are driving severe cases this season. Case numbers are definitely rising, though many with mild symptoms aren't testing. Among those tested, the positivity rate has increased proportionally."
Time of India
5 hours ago
- Time of India
Chhattisgarh records first Covid death of the year
Chhattisgarh has reported its first Covid death this year. An 86-year-old patient, who had multiple comorbidities and was on regular dialysis, died at a private hospital in Raipur on June 14, officials said on Monday. It's the first fatality in the state linked to the JN1 variant, said officials. Chhattisgarh has recorded 118 Covid-19 infections this year. There are 51 active cases in the state. Raipur: Chhattisgarh has reported its first Covid death this year. An 86-year-old patient, who had multiple comorbidities and was on regular dialysis, died at a private hospital in Raipur on June 14, officials said on Monday. It's the first fatality in the state linked to the JN1 variant, said officials. Chhattisgarh has recorded 118 Covid-19 infections this year. There are 51 active cases, of whom 41 are in home isolation, nine are on oxygen support, and one patient is in ICU. According to health officials, the 86-year-old, a native of Rajnandgaon, had multiple comorbidities, including chronic renal failure, hypertension, and interstitial lung disease. His condition worsened, and he tested positive for Covid during routine screening. He died on the same day due to complications related to his health issues, said officials. On Monday, the state reported 10 new cases, including three each from Raipur and Bilaspur, two from Durg and 1 each from Mahasamund and Surguja. The daily growth rate of Covid-19 stands at 23.1%, while the recovery rate is twice that at 56.4%. Health experts predict that the state could see around 50 more cases in the next 10 days, but three patients on average are recovering each day. Health authorities said that they are on alert after the Covid death. The govt has begun training technical and non-technical healthcare staff in district hospitals and health centres in sample collection and patient treatment. Covid cases have been recorded in nine districts - including Raipur, Durg, Bilaspur, Bastar, Surguja, Mahasamund and Bemetara. Health department has urged people with cold and flu symptoms to get tested for Covid.
